Primary Everolimus-Eluting Stenting Versus Balloon Angioplasty With Bailout Bare Metal Stenting of Long Infrapopliteal Lesions for Treatment of Critical Limb Ischemia
- 15 February 2011
- journal article
- research article
- Published by International Society of Endovascular Specialists in Journal of Endovascular Therapy
- Vol. 18 (1) , 1-12
Abstract
Purpose: To report the long-term outcomes of a single-center prospective study investigating primary placement of everolimus-eluting metal stents for recanalization of long infrapopliteal lesions compared to a matched historical control group treated with plain balloon angioplasty and provisional placement of bare metal stents in a bailout manner. Methods: The study included 81 patients (63 men; mean age 71 years, range 45–85) suffering from critical limb ischemia (CLI) and angiographically proven long-segment (at least 1 lesion >4.5 cm) de novo infrapopliteal artery disease who underwent below-the-knee revascularization with either primary placement of everolimus-eluting stents (n = 47, 51 limbs, 102 lesions) or angioplasty and bailout bare metal stenting (n=34, 36 limbs, 72 lesions). Clinical and angiographic follow-up was collected at regular time intervals. Primary clinical and angiographic endpoints included patient survival, major amputationfree survival, angiographic primary patency, angiographic binary restenosis (>50%), and overall event-free survival. Results were stratified according to endovascular treatment received. Multivariable Cox proportional hazards regression analysis was applied to adjust for confounding factors of heterogeneity. Results: Baseline demographics were well matched. No significant differences were identified between the 2 groups with regard to overall 3-year patient survival (82.2% versus 65.7%; p=0.90) and amputation-free survival (77.1% versus 86.9%; p=0.20). Up to 3 years, lesions fully covered with everolimus-eluting stents were associated with significantly higher primary patency [hazard ratio (HR) 7.98, 95% CI 3.69 to 17.25, pConclusion: Primary infrapopliteal everolimus-eluting stenting for CLI treatment significantly inhibits restenosis and improves long-term angiographic patency and overall patient event-free survival compared to balloon angioplasty and bailout bare metal stenting.Keywords
This publication has 32 references indexed in Scilit:
- Infrapopliteal balloon angioplasty for the treatment of chronic occlusive diseaseJournal of Vascular Surgery, 2009
- Infrapopliteal Balloon Angioplasty for Chronic Critical Limb Ischemia in Diabetic Patients with Uremia: When is it Worth the Effort?Journal of Vascular and Interventional Radiology, 2009
- Endovascular procedures for below the knee arteries in diabeticsAnnales de Cardiologie et d'Angéiologie, 2008
- Meta-analysis of infrapopliteal angioplasty for chronic critical limb ischemiaJournal of Vascular Surgery, 2008
- Drug-eluting stents in renal artery stenosisEuropean Radiology, 2007
- Intra-arterial Reteplase and Intravenous Abciximab in Patients with Acute Ischemic Stroke: An Open-label, Dose-ranging, Phase I StudyNeurosurgery, 2006
- Meta-analysis of alternate autologous vein bypass grafts to infrapopliteal arteriesJournal of Vascular Surgery, 2005
- The role of infrapopliteal angioplastyBritish Journal of Radiology, 2004
- Extensive use of peripheral angioplasty, particularly infrapopliteal, in the treatment of ischaemic diabetic foot ulcers: clinical results of a multicentric study of 221 consecutive diabetic subjectsJournal of Internal Medicine, 2002
- Prospective Trial of Infrapopliteal Artery Balloon Angioplasty for Critical Limb Ischemia: Angiographic and Clinical ResultsJournal of Vascular and Interventional Radiology, 2000